Drugs / Procure
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01456065 | Sep 2010 → Apr 2013 | malignant epithelial tumor of ovary | Life Research Technologies GmbH | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Procure | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01456065 ↗ |